Back

Inflammatory biomarkers and long-term outcome in young stable patients 3 months after a first myocardial infarction

26 August 2023 (14:40 - 14:50)
Organised by: Logo
Congress Presentation Part of: Markers of inflammation and outcomes in patients with acute coronary syndromes Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Sofia Cederstrom

Karolinska Institute, Stockholm (Sweden)

4 More presentations in this session

Presentation thumbnail
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition with evolocumab decreases myocardial inflammation in individuals with acute coronary syndrome (ACS)
Doctor E. Ziogos (Baltimore, US)
Abstract Slides Video
Presentation thumbnail
Synergistic effect of Interleukin-1beta and cholesterol efflux capacity on outcomes in acute myocardial infarction patients
Doctor C. Materne (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Analysis of immune infiltration and cuproptosis-related genes in acute myocardial infarction
Doctor Y. Xiao (Changsha, CN)
Abstract Slides Video
Presentation thumbnail
Impact of nutritional status and systemic immune-inflammation index on mortality in patients with acute myocardial infarction
Doctor H. Kwak (Daegu, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Markers of inflammation and outcomes in patients with acute coronary syndromes
Video

The Event

Event poster

ESC Congress 2023

26 August 2023 14:40 CET
You may be interested in
thumbnail
Congress Session
Markers of inflammation and outcomes in patients with acute coronary syndromes
thumbnail
Congress Presentation
Interleukin-6 and cardiovascular prognosis in apparently healthy individuals
thumbnail
Congress Session
Determinants of long-term outcome following acute myocardial infarction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources